Testing effectiveness (Phase 2)Study completedNCT01132313
What this trial is testing
Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 488